Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL439393 | 0.86 | RXFP1 (0.74) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL18989422 | 0.83 | RXFP1 (0.43) | RXFP1TRPV1TDP1L3MBTL1POLB | |
| SCHEMBL9162 | 0.80 | SMN1; SMN2 (0.61) | TRPV1TDP1L3MBTL1POLBKDM4E | |
| SCHEMBL17084525 | 0.80 | RXFP1 (0.67) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL390106 | 0.80 | TDP1 (0.64) | RXFP1TRPV1TDP1L3MBTL1POLB | |
| SCHEMBL124216 | 0.79 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL959539 | 0.79 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL8164496 | 0.77 | RXFP1 (0.62) | RXFP1TRPV1TDP1L3MBTL1POLB | |
| Hydrochloric Acid SCHEMBL7460090 | 0.77 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL5071228 | 0.77 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11035080-B2 | Boronic acid containing polymers for papermaking process | ECOLAB USA INC. (US) | 2021-06-15 | — | — | US | claimed |
| EP-3390715-B1 | BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS | ECOLAB USA INC (US) | 2020-12-02 | — | — | EP | claimed |
| US-20180327972-A1 | BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS | ECOLAB USA INC. (US) | 2018-11-15 | — | — | US | claimed |
| EP-3390715-A1 | BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS | Ecolab USA Inc. (US) | 2018-10-24 | — | — | EP | claimed |
| WO-2017106310-A1 | BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS | ECOLAB USA INC. (US) | 2017-06-22 | — | — | WO | claimed |
| US-20120097540-A1 | MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS | JAMES TONY DAVID (GB) | 2012-04-26 | — | — | US | claimed |
| US-11035080-B2 | Boronic acid containing polymers for papermaking process | ECOLAB USA INC. (US) | 2021-06-15 | — | — | US | disclosed |
| US-10765110-B2 | Agent for preserving biological component | Tabata, Yasuhiko (JP) | 2020-09-08 | — | — | US | disclosed |
| US-20170311586-A1 | AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT | Tabata, Yasuhiko (JP) | 2017-11-02 | — | — | US | disclosed |
| EP-3219787-A1 | AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT | Denka Company Limited (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-20120097540-A1 | MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS | JAMES TONY DAVID (GB) | 2012-04-26 | — | — | US | disclosed |
| EP-2344885-A2 | MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS | The University of Bath (GB) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010041037-A2 | MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS | THE UNIVERSITY OF BATH (GB) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170311586-A1 | AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT | CD44, HPSE, PLOD3 | RXFP1 1729/4885TRPV1 3934/4885TDP1 1243/4885 |
| US-10765110-B2 | Agent for preserving biological component | CD44, MUC1, PLOD3 | RXFP1 2283/4885TRPV1 3855/4885TDP1 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.